In trading on Thursday, shares of MGE Energy Inc (Symbol: MGEE) crossed below their 200 day moving average of $87.24, changing hands as low as $86.47 per share. MGE Energy Inc shares are currently ...

The first Mortal Kombat 2 movie poster is deceptive about the film it is promoting. Fans are interested to see Karl Urban in the role of Johnny Cage in the upcoming sequel. Mortal Kombat 2 boasts ...

LAKEVILLE, Minn — The Lakeville Public School District Board voted to remove the district's "Inclusive Poster Series" Tuesday night. The poster series features eight posters, with messages ...

A new film poster for Mortal Kombat 2 has been released, giving a first look at Karl Urban's Johnny Cage. "Uncaged fury" reads the poster, with Urban posing as Cage wearing iconic shades in front ...

Add articles to your saved list and come back to them any time. In the art world, collectors pay huge sums for rarities. One of only four surviving copies of the original German poster for the ...

Captain America: Brave New World is nearly here and Marvel Thailand has just dropped a couple of unique posters to hype up the movie's release. While we obviously won't see these costumes in The ...

Dwarf Fortress is often called the most complex video game ever made. While that claim is difficult to verify, it can undeniably be quite intimidating to newcomers, with dozens of menus to sort ...

This photo provided by Kanagawa Prefectural Police shows posters created using generative AI that are suspected of infringing the copyrights of popular anime franchises. YOKOHAMA -- Police in ...

Dwarf Fortress is still the champion when it comes to the most in-depth sandbox games on PC, but there’s another side of it that’s just as rich and rewarding, and perhaps even an easier way to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Fortress Biotech (FBIO) and its majority-owned subsidiary, Helocyte, announced that the first patient was dosed in a multicenter, placebo-controlled and randomized Phase 2 clinical trial to ...